Skip to content

Performance Study for InferRead CT Pneumonia.AI

Performance Study for InferRead CT Pneumonia.AI

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04955704
Enrollment
423
Registered
2021-07-09
Start date
2021-09-01
Completion date
2022-01-31
Last updated
2021-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Brief summary

A retrospective, blineded, multicenter study of the InferRead CT Pneumonia.AI to evaluate the performance in identifying non-contrast chest CT scans containing pneumonia findings.

Detailed description

This is a retrospective, blinded, multicenter study for the InferRead CT Pneumonia.AI. The primary endpoint will evaluate the software's performance in identifying non-contrast chest CT scans containing pneumonia. It will evaluate InferRead CT Pneumonia.AI in terms of sensitivity and specificity with respect to a ground truth, as established by trained thoracic radiologists, in the detection of penumonia. In addition, the study will compare time to notification for the InferRead CT Pneumonia.AI software with respect to the time to notification for the standard of care as established from available radiological reports. 1. To evaluate the performance of InferRead CT Pneumonia.AI. 2. To evaluate the effect of different factors such as CT manufacturer, CT scanning protocols and patient characteristics on the performance of InferRead CT Pneumonia.AI

Interventions

DEVICEInferRead CT Pneumonia.AI

InferRead CT Pneumonia.AI reads chest CT DICOM images from medical imaging storage devices and triages cases by detecting pneumonia lesions and then flagging suspected cases in the study list. InferRead CT Pneumonia.AI is a tool to assist clinicians and it does not replace the interpretation and diagnosis by clinicians.

Sponsors

University of Maryland, College Park
CollaboratorOTHER
Infervision
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Non-contrast chest CT DICOM scans 2. Contains both lung lobes 3. Slice thickness is less than 3 mm.

Exclusion criteria

1. Incomplete scan or corrupted scan 2. Irregular scanning, increased intrapulmonary density due to insufficient inspiration, and respiratory artifacts affecting the physician's judgment. 3. Altered or absent lung morphology in the postoperative patient.

Design outcomes

Primary

MeasureTime frameDescription
Primary Endpoint1/1/2022 - 2/28/20221. The Sensitivity (SE) of InferRead CT Pneumonia.AI is higher than 0.80. H0: YSE ≤ 0.80 HA: YSE \> 0.80 2. The Specificity (SP) of InferRead CT Pneumonia.AI is higher than 0.80. H0: YSP ≤ 0.80 HA: YSP \> 0.80

Secondary

MeasureTime frameDescription
Secondary Endpoint1/1/2022 - 2/28/2022The Average Per Case Processing Time of InferRead CT Pneumonia.AI is lower than Time-to-open-exam in the standard of care H0: Per Case Processing Time ≥ Time-to-open-exam HA: Per Case Processing Time \< Time-to-open-exam The Average Per Case Processing Time of InferRead CT Pneumonia.AI includes the time to receive the DICOM exam and the shows AI results on the studylist. The standard of care time-to-open-exam is defined as the time from the initial scan of the patient to the time when the radiologist first opens the exam for review.

Contacts

Primary ContactFrank Wu
frank.wu@infervision.ai8579981888

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026